BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 16212004)

  • 41. Fibrosis in alcoholic and nonalcoholic steatohepatitis.
    Bataller R; Rombouts K; Altamirano J; Marra F
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):231-44. PubMed ID: 21497741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonalcoholic fatty liver disease and metabolic syndrome: a concise review.
    Streba LA; Cârstea D; Mitruţ P; Vere CC; Dragomir N; Streba CT
    Rom J Morphol Embryol; 2008; 49(1):13-20. PubMed ID: 18273497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Babini M
    Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.
    Videla LA; Rodrigo R; Araya J; Poniachik J
    Free Radic Biol Med; 2004 Nov; 37(9):1499-507. PubMed ID: 15454290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonalcoholic fatty liver disease: defining a common problem.
    Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-alcoholic fatty liver disease in Malaysia: a demographic, anthropometric, metabolic and histological study.
    Malik A; Cheah PL; Hilmi IN; Chan SP; Goh KL
    J Dig Dis; 2007 Feb; 8(1):58-64. PubMed ID: 17261137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonalcoholic fatty liver disease as a complication of insulin resistance.
    Abdelmalek MF; Diehl AM
    Med Clin North Am; 2007 Nov; 91(6):1125-49, ix. PubMed ID: 17964913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent advances in nonalcholic fatty liver disease.
    Greenfield V; Cheung O; Sanyal AJ
    Curr Opin Gastroenterol; 2008 May; 24(3):320-7. PubMed ID: 18408460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease.
    Day CP
    Liver Int; 2006 Nov; 26(9):1021-8. PubMed ID: 17032401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic and environmental susceptibility to non-alcoholic fatty liver disease.
    Day CP
    Dig Dis; 2010; 28(1):255-60. PubMed ID: 20460920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver pathology in obesity.
    Suriawinata A; Fiel MI
    Semin Liver Dis; 2004 Nov; 24(4):363-70. PubMed ID: 15605304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treating nonalcoholic fatty liver disease.
    Méndez-Sánchez N; Arrese M; Zamora-Valdés D; Uribe M
    Liver Int; 2007 Nov; 27(9):1157-65. PubMed ID: 17919226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.
    Preiss D; Sattar N
    Clin Sci (Lond); 2008 Sep; 115(5):141-50. PubMed ID: 18662168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonalcoholic fatty liver disease: is all the fat bad?
    Clouston AD; Powell EE
    Intern Med J; 2004 Apr; 34(4):187-91. PubMed ID: 15086699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of oxidative stress in non-alcoholic steatohepatitis.
    Koek GH; Liedorp PR; Bast A
    Clin Chim Acta; 2011 Jul; 412(15-16):1297-305. PubMed ID: 21514287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Alcoholic and non-alcoholic steatohepatitis].
    Denk H; Stumptner C; Fuchsbichler A; Zatloukal K
    Verh Dtsch Ges Pathol; 2005; 89():137-43. PubMed ID: 18035683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.